Cargando…
934. Diagnostic Utility of Blood (1- >3)-β-D-Glucan Testing in Patients with HIV in Arkansas
BACKGROUND: Blood (1- > 3)-β-D-Glucan (BDG) is a sensitive marker for Pneumocystis jirovecii pneumonia (PJP) in patients with AIDS (PWA). However, other fungal infections, including progressive disseminated histoplasmosis (PDH), cause high levels of BDG. At our hospital, PDH is a common diagnosis...
Autores principales: | Krishnan, Gayathri, Hasan, Lana, Saccente, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7776117/ http://dx.doi.org/10.1093/ofid/ofaa439.1120 |
Ejemplares similares
-
93. A Diagnostic Stewardship Intervention to Improve Utilization of 1,3-β-D-glucan Testing
por: Kendall, Jonathan A, et al.
Publicado: (2020) -
934. Epidemiology and Outcomes of Epstein-Barr Virus DNAemia in Adult Solid Organ Transplant Recipients
por: Dong, Sara W, et al.
Publicado: (2021) -
P934: THE EFFECTS OF EXTRAMEDULLARY DISEASE ON OUTCOMES OF PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA
por: Tao, Yi, et al.
Publicado: (2023) -
1701. Differences in Diagnostic Performance of β-d-Glucan Testing in Patients with Varying Degrees of Susceptibility to Invasive Fungal Infections
por: Nham, Eliel, et al.
Publicado: (2019) -
279. Evaluation of β-d-Glucan Utilization in Thailand: Single Academic Center Experience
por: Manothummetha, Kasama, et al.
Publicado: (2019)